⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer

Official Title: A Phase II Randomized Study of Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care Alone in Patients With Advanced Colorectal Adenocarcinoma Refractory to Standard Therapies

Study ID: NCT02870920

Study Description

Brief Summary: The standard or usual treatment for this disease is treatment with drugs and other treatments that may help to make a patient better or may improve their quality of life. This treatment is known as "best supportive care" (BSC). Although patients with best supportive care can feel better for some months, the cancer usually continues to grow.

Detailed Description: Durvalumab is a new type of drug for many types of cancer. Laboratory tests show that it works by allowing the immune system to detect cancer and reactivate the immune response. This may help to slow down the growth of cancer or may cause cancer cells to die. Durvalumab has been shown to shrink tumours in animals and has been studied in a few people and seems promising but it is not clear if it can offer better results than standard treatment alone. Tremelimumab is a new type of drug for various types of cancers. It works in a similar way to durvalumab and may improve the effect of durvalumab. This may also help slow the growth of the cancer cells or may cause cancer cells to die. Tremelimumab has been shown to shrink tumours in animals and has been studied in a few people and seems promising but it is not clear if it can offer better results than standard treatment alone when used with durvalumab. Combinations of durvalumab and tremelimumab have also been studied and when combined have been shown to increase tumour shrinkage in animals compared to either drug alone and while the combination has been studied in a few people, it is not clear if it can offer better results than standard treatment.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Tom Baker Cancer Centre, Calgary, Alberta, Canada

BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada

The Moncton Hospital, Moncton, New Brunswick, Canada

Dr. H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador, Canada

QEII Health Sciences Centre, Halifax, Nova Scotia, Canada

Royal Victoria Regional Health Centre, Barrie, Ontario, Canada

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

Cancer Centre of Southeastern Ontario at Kingston, Kingston, Ontario, Canada

London Regional Cancer Program, London, Ontario, Canada

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

Algoma District Cancer Program, Sault Ste. Marie, Ontario, Canada

Odette Cancer Centre, Toronto, Ontario, Canada

University Health Network, Toronto, Ontario, Canada

Windsor Regional Cancer Centre, Windsor, Ontario, Canada

Hopital Charles LeMoyne, Greenfield Park, Quebec, Canada

Hopital de la Cite-de-la-Sante, Laval, Quebec, Canada

L'Hotel-Dieu de Levis, Levis, Quebec, Canada

CHUM - Hopital Notre-Dame, Montreal, Quebec, Canada

The Jewish General Hospital, Montreal, Quebec, Canada

Centre Integre Universitaire De Sante Et De Services, Montreal, Quebec, Canada

CHUQ-Pavillon Hotel-Dieu de Quebec, Quebec City, Quebec, Canada

Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada

Centre hospitalier regional de Trois-Rivieres, Trois-Rivieres, Quebec, Canada

Allan Blair Cancer Centre, Regina, Saskatchewan, Canada

Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada

Contact Details

Name: Eric Chen

Affiliation: Univ. Health Network-Princess Margaret Hospital, Toronto ON Canada

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: